Scientists have initiated a study to investigate whether dapagliflozin, an already approved drug from the SGLT2 inhibitors group, can positively affect the course of autosomal dominant polycystic ...
Dapagliflozin reduced left ventricular mass index early into treatment in patients with nondialysis-dependent CKD, regardless of disease etiology and cardiovascular history. Dapagliflozin reduces left ...
Inquirer.net on MSN
More medicines vs cancer, diabetes now VAT-exempt
The Bureau of Internal Revenue (BIR) has approved an updated set of medicines that are exempted from the value-added tax (VAT) following the Food and Drug Administration’s (FDA) endorsement of ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
Prolynx was founded by Daniel Santi, M.D., Ph.D., and Gary Ashley, Ph.D., who have spent over a decade refining the chemistry of sustained drug release. Dr. Santi will continue to lead the company’s ...
AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...
News Medical on MSN
Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
A. Dandruff and seborrheic dermatitis both cause itching and flaking of the scalp or skin. They may be reactions to the ...
The FDA has now started a review of the highly anticipated drug, and AZ is using a priority review voucher to shorten the ...
HOUSTON -- Adding an investigational nonsteroidal mineralocorticoid receptor antagonist (MRA) to an SGLT2 inhibitor led to a superior reduction in albuminuria among chronic kidney disease patients at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback